BOPI 11 BR/2024 REPERTOIRE NUMERIQUE 19 Fig. 41 ________________________________________ (11) 21699 Consulter le mémoire (51) A61K 31/00 (2023.01); A61P 1/16 (2023.01); A61P 25/00 (2023.01); A61P 29/00 (2023.01); A61P 35/00 (2023.01) ; C07F 9/74 (2023.01) (21) 1202400117 (22) 30/09/2022 (30) CN n° 202111162542.5 du 30/09/2021 (54) Halogenated phenylarsine oxide compound and application thereof. (72) HUANG Fude (CN); HONG Feng (CN); WANG Wenan (CN); ZHANG Jiangang (CN); XIE Yuyu (CN); ZHANG HAO (CN); JIAO Changping (CN); CAO Luxiang (CN); ZHENG Linan (CN); HUANG Changde (CN); HOU Lijuan (CN); MA Liping (CN); LU Jinlian (CN); FANG Li (CN) et AN Peiyun (CN) (73) NUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGAI) CO., LTD., 4560 Jinke Road, Zhangjiang Hi-Tech Park, SHANGHAI 201210 (CN) (74) S.C.P AKKUM, AKKUM & Associates, No. 1777, rue 6.261, Yaoundé 2, Auditorium Jean Paul II boulevard, Face Brigade de Gendarmerie, Mbankolo, B.P. 4966, YAOUNDE (CM). (57) A fluorinated phenylarsine oxide or a pharmaceutically acceptable salt thereof, relating to a pharmaceutical composition containing a pharmaceutically acceptable carrier and a fluorinated phenylarsine oxide. The fluorinated phenylarsine oxide can be used for treating and preventing cancer and related disease. ________________________________________ (11) 21700 Consulter le mémoire (51) C25C 1/12 (2023.01); C25D 21/04 (2023.01) ; C25D 3/38 (2023.01) (21) 1202400128 (22) 07/10/2022 (30) US n° 63/253,349 du 07/10/2021 et US n° 63/297,842 du 10/01/2022 (54) Acid mist suppression in copper electrowinning.
RkJQdWJsaXNoZXIy MTM1NDc3MA==